Terry Grimm
Niowave, Inc., Lansing, MI

Abstract
In March 2015 the Nuclear Regulatory Commission approved Niowave’s license to produce Mo-99 from a low enriched uranium target using a superconducting electron linac. The first domestic production of small quantities of Mo-99 from uranium occurred in September 2015 with plans to increase the production rate to kCi per week quantities by 2021. Also, over the past year Niowave has built up its radiochemistry facilities and personnel to chemically separate Mo-99 and other valuable fission fragments.  The radiochemistry facility is located at the same location that the low enriched uranium is irradiated. Niowave will give an update and progress on the technical and licensing plans.

Bio
Terry Grimm (pictured right) received his BS with highest honors in Nuclear Engineering from Purdue University in 1987. He then attended the Massachusetts Institute of Technology, where he received his PhD in Nuclear Engineering and Plasma Physics. For the first 20 years of his career he developed particle accelerators for DOE and NSF (Superconducting Super Collider, National Superconducting Cyclotron Laboratory and Facility for Rare Isotope Beams). In 2005, Terry founded Niowave, Inc. to commercialize superconducting electron linear accelerators in fields as diverse as health care and national security. In 2010 he received the IEEE Entrepreneurship Award in Applied Superconductivity.